Claim the "No.1 Coin of 2025" Before March 24th
After spotting 44 different coins that have returned over 100%...Chris Rowe is now exposing the details behind the "Superpower Coin"... that's partnered with 19 of the largest companies from some of the world's largest superpower nations... A little-known 3-cent coin that is poised to outperform Bitcoin in 2025... starting on March 24th.
Shares Stats
| Shares Outstanding | 129,290,000 |
| Shares Float | 123,760,000 |
| Shares Short | 2,490,000 |
| Insider Holdings | 390% |
| Institution Holdings | 96.89% |
About Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference. It offers ONPATTRO and AMVUTTRA for hereditary transthyretin-mediated amyloidosis; GIVLAARI for acute hepatic porphyria; OXLUMO for primary hyperoxaluria type 1; and Leqvio for hypercholesterolemia. It also develops vutrisiran, which is in phase III clinical trial for transthyretin amyloidosis (ATTR) with cardiomyopathy; Nucresiran that is in phase I clinical trial for ATTR amyloidosis; Fitusiran, which is in phase III clinical trial for hemophilia; cemdisiran that is in phase III clinical trial for Myasthenia Gravis and paroxysmal nocturnal hemoglobinuria, and geographic atrophy; and ALN-6400, which is in phase I clinical trial for bleeding disorders. In addition, the company is also developing Zilebesiran, which is in phase II clinical trial for hypertension; Rapirosiran that is in phase II clinical trial for Metabolic dysfunction-associated steatohepatitis; ALN-4324, which is in phase I clinical trial for type 2 diabetes mellitus; ALN-PNP that is in phase I clinical trial for non-alcoholic fatty liver disease; ALN-APOC3, which is in phase I clinical trial for dyslipidemia; Mivelsiran that is in phase II clinical trial for cerebral amyloid angiopathy, and phase I clinical trial for Alzheimer's disease; and ALN-HTT02 that is in phase I clinical trial for Huntington's disease. Further, it develops ALN-SOD, which is in phase II clinical trial for SOD1 Amyotrophic lateral sclerosis; Elebsiran that is in phase II clinical trial for Hepatitis B and D virus infections; ALN-BCAT that is in phase I clinical trial for hepatocellular carcinoma; and ALN-ANG3. It has collaborations with Regeneron Pharmaceuticals, Inc.; Roche Holding AG; Regeneron Pharmaceuticals, Inc.; Sanofi S.A.; Novartis AG; PeptiDream, Inc; Dicerna Pharmaceuticals, Inc.; and Ionis Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
General
| Name | Alnylam Pharmaceuticals Inc |
| Ticker | ALNY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 2,230 |
Highlights
| Analyst Target | 309.59 |
| Market Cap | 31,297,600,000 |
| PEG Ratio | -0.49 |
| EBITDA | -120,215,000 |
Financials
| Curr Year EPS Estimate | 0.52 |
| Next Quarter EPS Estimate | -0.53 |
| Profit Margin | -12.37% |
| Operating Margin | -7.87 |
| Return on Assets | -0.03 |
| Return on Equity | -15.01 |
| Revenue | 2.2B |
| Earnings Per Share | -2.18 |
| Revenue Per Share | 17.61 |
| Gross Profit | 1,924,872,960 |
| Quarterly Revenue Growth | 0.35 |
Valuation
| Forward PE | 909.09 |
| Price/Sales (Trailing 12 Mt.) | 13.92 |
| Price/Book (Most Recent Quarter) | 466.52 |
Earnings
CDC Considers New Autism Study As Vaccine Safety Debate Persists
The CDC is planning a large study on potential vaccinAutism's links, despite extensive research dismissing any connection.
VP Vance Slams Pro-Ukraine Protesters for Confronting Him With His Daughter: 'Chasing a Three-Year-Old for Politics'
Vice President Vance recently found himself confronted by a group of pro-Ukraine protestors while out with his young daughter in Ohio.
The Fort Knox Cover-up? What It Means for Gold - Ad
Trump and Musk are demanding answers: Is Fort Knox empty? If the gold is gone, supply collapses, and prices could skyrocket instantly. Right now, I've uncovered 5 major gold predictions that could make this Fort Knox moment even bigger than people realize. One of them is already unfolding--and the window to act is closing fast.
Analyst Sees Wendy's Playing Catch-Up, Needs Stronger Focus on Tech, Talent & Global Expansion
J.P. Morgan analyst Rahul Krotthapalli maintains a Neutral rating on Wendy's with a $17 price target. Despite its strong U.S. presence, Wendy's faces a sub-1x sales/investment ratio.
Elon Musk's xAI Acquires 1-Million-Square-Foot Property In Memphis For Supercomputer Expansion
Elon Musk's xAI has acquired a 1-million-square-foot property in Memphis to expand its Colossus supercomputer.
Wall Street Legend Now Calling Exact Day Next Market Crash Will Start? - Ad
Perhaps no one on or off Wall Street has more accurate in calling the market turns of the past 7 years. From the bear markets of 2018 and 2022... to the roaring bull runs of 2021, 2023, and 2024. And now, Marc Chaikin is predicting the exact month (even the exact day!) the next crash is most likely to start--don't miss this huge and important new call.
Wall Street Drop Deepens As Trade War Fears Escalate, S&P 500 Hits 7-Month Lows: What's Driving Markets Tuesday?
Nasdaq 100 drops 0.6%, S&P 500 slides to 7-month low, Dow Jones industrials underperform.
How to roll over an old 401(k)
Old are a little like the old clothes in the back of your closet. You know you should do something about them, but there they sit, mostly out of sight and mind.
Trump Bombshell to Hit by April 30th? - Ad
According to Louis Navellier, the legendary investor who picked Nvidia before shares exploded as high as 3,423%... Before April 30th, President Trump could make a shocking AI announcement... Sending these stocks exploding higher.
Takeaways from our investigation on AI-powered school surveillance
Thousands of American schools are turning to surveillance technology for 24/7 monitoring of student accounts and school-issued devices like laptops and tablets.
Trump Threatens Russia With Sanctions Amid Ukraine Conflict As He Pushes For Peace
President Donald Trump is contemplating imposing extensive sanctions and tariffs on Russia. This move aims to pressure Russia into a peace agreement in the ongoing conflict with Ukraine.
The Trump Dump Is Starting; Get Out of Stocks Now? - Ad
You're still in stocks...Are you nuts?! Yes, I fully expect the Trump presidency will be the best time to get rich in American history...With 12,000% gains available soon. But, I'm not talking about stocks, nor bitcoin. Over the next 12 months, a modest $900 investment...Could grow to a life-changing $108,000.
Kroger Chairman and CEO resigns following investigation into personal conduct
Kroger Chairman and CEO Rodney McMullen has resigned after an internal investigation into his personal conduct.
Oracle's Q3 Falls Short, But AI Demand Keep Long-Term Outlook Strong Say Analysts
Oracle shares are down after disappointing Q3 results. Analysts maintain ratings, but lower price targets and highlight strong AI growth.
Strange Pattern Emerges in U.S. Stock Market - Ad
A rare stock market anomaly--seen only once this century--is back! Last time, it helped create gains as high as 125,000% over 15 years. Now, it's colliding with the AI boom, and people are taking notice. The Oxford Club's top strategist reveals how to profit--watch the special broadcast now!
China's foreign minister blasts the US over tariffs at his annual meeting with journalists
TAIPEI, Taiwan (AP) — Along with against the United States, China’s Foreign Minister Wang Yi reasserted China’s South China Sea claims, blasted Japan for its past aggression and covered a wide range of other issues during his annual meeting with the press. Here are some of the key topics covered during his Friday press conference.
Tesla Out, Ford In: City Of Baltimore Goes 'In A Different Direction' Reversing EV Deal From 2024
Tesla is losing an EV city fleet deal in Baltimore to Ford. A look at what happened and how politics may have factored into the decision.
Strikes and Economic Unrest: Are You Prepared for What's Coming? - Ad
Louis Navellier has issued a chilling warning about the economic turmoil gripping America today. The rapid advancement of artificial intelligence and automation is reshaping industries and posing threats to jobs, pushing America's financial system to its limits. If you're not prepared, it could devastate your savings, investments, and even your retirement.
Alibaba Unveils New AI Chip To Power China's Open-Source Tech Push, Challenge US Chip Giants
Alibaba's new processor, XuanTie C930, boosts China's semiconductor industry by promoting open-source chips & AI acceleration, amid US sanctions.
UK Commits Export Financing For Ukraine's Air Defense Amid Ongoing Russia-Ukraine Conflict
In the midst of the Russia-Ukraine conflict, the United Kingdom has stepped up to provide export financing for Ukraine's air defense.
Just Released: Huge New A.I. Trade - Ad
While everyone's distracted by Nvidia, PLTR & Bitcoin, billionaires have been quietly loading up on this stock. And 99% of Americans have no clue. It could help make a fortune for fast-moving investors, who make their move before March 19.
What's Going On With United Microelectronics Stock Today?
United Microelectronics shares are down in premarket trading, despite reporting a 4.25% increase in February sales year-over-year.
Sam Bankman-Fried Says 'When Rubber Meets The Road' On Crypto's Fate Under Trump, Slams Biden's Policies
Disgraced cryptocurrency mogul Sam Bankman-Fried weighed in on the future of digital assets under President Donald Trump’s administration, according to an interview from his prison released Thursday.
Own AI Stocks? Do This Before March 17th - Ad
This tiny tech--smaller than a quarter--could ignite the next AI boom by March 17th! It's powering Elon Musk's $9T project, and one "silent partner" stock could skyrocket. If you missed Nvidia's 22,000% run, this could be your second chance. Click now--before it's too late!
Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025
Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for mid-2025.
Magnificent 7 Sheds Over $750 Billion In Market Cap In One Day: Is Big Tech's Honeymoon Over? (CORRECTED)
The Magnificent Seven tech companies, including Tesla, which make up 30% of the S&P 500, saw major losses on Monday due to recession fears.
Millionaire Trader: "My No. 1 Stock of the Decade" (Revealed Free) - Ad
The stock revealed right here just may be millionaire trader Jeff Clark's favorite stock ever. Because this one stock alone has been responsible for some of the biggest gains he's ever handed my readers... 195% in under a month... 85% in 14 days... 176% in 5 weeks... 120% in under 3 months... 55% in two days... 138% in 8 days... And even 222% in 8 days.
China imposes retaliatory tariffs on Canadian farm and food products
BEIJING (AP) — China on Saturday announced retaliatory tariffs on some Canadian farm and food imports, after Canada imposed duties in October on Chinese-made electric vehicles and steel and aluminum products.
Miu Miu celebrates femininity with a star-studded cast at Paris Fashion Week show
PARIS (AP) — At Miu Miu, the little sister brand of , the feminine wasn’t just celebrated — it was deconstructed, reconfigured and worn with a wink.
[Revealed] Trump and Elon's Shocking New Plan for America - Ad
Three patents could help President Trump and Elon Musk completely revolutionize a $23 Trillion market. This revolution is about so much more than just self-driving cars. Instead, what Elon's pivoting Tesla towards... Is a market that's 1,000X BIGGER. But a project THIS big can't stay under the radar for long...
Tesla Stock Pares Early Losses, Rises 6.4% After Key Signal
A significant trading signal occurred for Tesla stock, as it demonstrated a Power Inflow at $222.68, after which TSLA rose up to 6.4%.
Donald Trump's 'The Apprentice' Reality Show Gets Streaming Home, Here's Where You Can Watch Him Tell People They're Fired
On "The Apprentice," contestants competed to win a job with Trump and $250,000 salary. The people who lost were famously told, "You're fired."
Nvidia Is About to Shock the World: March 17th - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: March 17th! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Asian shares slip as investors brace for further uncertainty over tariffs, await US jobs report
BANGKOK (AP) — Asian shares were mostly lower on Friday, with Tokyo’s benchmark down more than $2 after a on Wall Street.
The U.S. penny costs nearly 4 cents to make. But for one sector of souvenir sellers, it's a living
NEW YORK (AP) — Donald Trump talks of big change in his second term of office. But he's not forgetting small change, either.
The $20 Trillion Secret of Room 3330 - Ad
Developed by the U.S. military 79 years ago, this controversial technology is about to change American life forever: Elon Musk has already funneled $6 billion to resurrect this covert project -- and the companies involved are minting 10,000 millionaires every week [Goldman Sachs].
Explainer: What's a recession and why is rising anxiety about it roiling markets?
WASHINGTON (AP) — Stock markets , consumers and businesses have started to , and economists are marking down their estimates for growth this year, with some even seeing rising odds of a recession.
Cathie Wood Goes On Shopping Spree Amid Tech Bloodbath Monday: Loads Up On Tesla, Palantir, Coinbase And These Stocks
On Monday, Cathie Wood‘s Ark Invest made significant trades involving Tesla Inc. (NASDAQ:TSLA) , Palantir Technologies Inc. (NASDAQ:PLTR), Coinbase Global Inc. (N
The Gold Shift No One's Talking About - Yet - Ad
Massive gold shipments are quietly moving from London to the U.S.--no headlines, no explanations. Could a full-scale audit or a new gold-backed system be coming? Smart money isn't waiting. My gold strategy is already doubling physical gold's returns this year.
Stock market today: Asian stocks are mixed as week starts with uncertainty over tariffs
BANGKOK (AP) — Asian stocks got a mixed start to trading Monday as uncertainty persisted over what President will do with tariffs.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.